Brind.

Analysts raised price targets on Bristol-Myers Squibb shares.

1 report, 1 independent Updated Aug 26

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Bristol-Myers Squibb

Keep exploring

The entities involved

Bristol-Myers Squibb
American pharmaceutical company
- Pfizer, J&J, BMS, Sanofi, and AbbVie are leading innovation in personalized therapies and are key players in the multiple myeloma treatment market.Thu 14:49
- BMS, Eli Lilly, and Novo Nordisk are advancing GLP-1 portfolios, investing in manufacturing, and navigating regulatory approvals.Thu 13:45

Coverage

Newest first; wire copies grouped

Aug 26themarketsdaily.com